APA (7th ed.) Citation

CH, W., JJ, P., Z, L., CY, M., YL, L., ZX, L., . . . Y, C. (2026). Exosomal CircGANAB promotes cancer progression and immunotherapy resistance by degrading interacting RNAs and limiting T cell infiltration in pancreatic ductal adenocarcinoma. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 87, 101416. https://doi.org/10.1016/j.drup.2026.101416

Chicago Style (17th ed.) Citation

CH, Wong, et al. "Exosomal CircGANAB Promotes Cancer Progression and Immunotherapy Resistance by Degrading Interacting RNAs and Limiting T Cell Infiltration in Pancreatic Ductal Adenocarcinoma." Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 87 (2026): 101416. https://doi.org/10.1016/j.drup.2026.101416.

MLA (9th ed.) Citation

CH, Wong, et al. "Exosomal CircGANAB Promotes Cancer Progression and Immunotherapy Resistance by Degrading Interacting RNAs and Limiting T Cell Infiltration in Pancreatic Ductal Adenocarcinoma." Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, vol. 87, 2026, p. 101416, https://doi.org/10.1016/j.drup.2026.101416.